Concepedia

Lori Capone

LC

8

Publications

1.2K

Citations

8

H-Index

2009

Active since

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

Lori Capone is an author at Bristol-Myers Squibb (Switzerland) specializing in medicine, pharmacotherapy, and immune regulation.

Top concepts

Publications per year

2009–2019

8

Publications

8

Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity <i>in vitro</i> and in a model of psoriasis

PH Schafer, Andrew Parton, Lori Capone et al. · British Journal of Pharmacology · 2009 · 397 citations · Full text

Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity

Peter Schäfer, Anastasia Parton, Lori Capone et al. · Cellular Signalling · 2014 · 302 citations · Full text

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

Anita K. Gandhi, Jingfen Kang, Lori Capone et al. · Current Cancer Drug Targets · 2010 · 167 citations

, , +18

Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration

Matthew Hoffmann, Claudia Kasserra, Josephine Reyes et al. · Cancer Chemotherapy and Pharmacology · 2012 · 120 citations · Full text

Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study

Peter Schäfer, Alan Kivitz, Jianglin Ma et al. · Rheumatology and Therapy · 2019 · 64 citations · Full text

Rows per page

1–5 of 8